These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8081082)

  • 1. Hepatitis C infection in patients with hemophilia: results of a national survey. Canadian Hemophilia Clinic Directors Group.
    Blanchette V; Walker I; Gill P; Adams M; Roberts R; Inwood M
    Transfus Med Rev; 1994 Jul; 8(3):210-7. PubMed ID: 8081082
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibodies against hepatitis C virus in French hemophiliacs].
    Maisonneuve P; Laurian Y; Noël L; Guérois C; Assouvie-Gomez I; Ferrer-Le Coeur F; Verroust F; Couroucé AM; Saint-Paul B
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):375-7. PubMed ID: 2177602
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-HCV and recipients: situation in hemophiliacs in 1991].
    Maisonneuve P; Couroucé AM; Ferrer le Coeur F; Guérois C; Laurian Y; Magniez M; Parquet-Gernez A; Verroust F; Noël L
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):193-8. PubMed ID: 1384524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune status of HIV and HCV negative haemophiliacs treated with intermediate-purity factor VIII concentrates.
    Funk M; Ebener U; Kreuz W; Ehrenforth S
    Lancet; 1993 Oct; 342(8876):933-4. PubMed ID: 7692198
    [No Abstract]   [Full Text] [Related]  

  • 5. High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels.
    Rumi MG; Colombo M; Gringeri A; Mannucci PM
    Ann Intern Med; 1990 Mar; 112(5):379-80. PubMed ID: 2106281
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.
    Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R
    Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody to hepatitis C (anti C 100-3) in French hemophiliacs.
    Maisonneuve P; Laurian Y; Guerois C; Verroust F; Ferrer Le Coeur F; Couroucé AM; Noel L
    Nouv Rev Fr Hematol (1978); 1991; 33(3):263-6. PubMed ID: 1956764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C antibody profile and viraemia prevalence in adults with severe haemophilia.
    Tedder RS; Briggs M; Ring C; Tuke PW; Jones P; Savidge GF; Rodgers B; Garson JA
    Br J Haematol; 1991 Nov; 79(3):512-5. PubMed ID: 1721527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of haemophilia.
    Jones P
    Arch Dis Child; 1984 Nov; 59(11):1010-2. PubMed ID: 6439126
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis C antibodies in children and adolescents with congenital blood coagulation disorders].
    Zenz W; Hofmann H; Muntean W
    Wien Klin Wochenschr; 1991; 103(3):69-72. PubMed ID: 1851352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A preliminary study of HCV infections with hemophilia and their family members].
    Sun HY; Li ZX; Liu WL; Xu HZ; Yang SH; Tang JZ; Hao LJ
    J Tongji Med Univ; 1994; 14(3):178-80. PubMed ID: 7528820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of post-transfusion non-A, non-B hepatitis].
    Habibi B; Smilovici W
    Rev Fr Transfus Immunohematol; 1988 Oct; 31(3):537-86. PubMed ID: 3144032
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of antibodies against hepatitis C virus in Norwegians with congenital coagulation factor defects treated with plasma products from small pools.
    Rollag H; Evesen SA; Fröland SS; Glomstein A
    Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):612-4. PubMed ID: 2170135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates.
    Garson JA; Tuke PW; Makris M; Briggs M; Machin SJ; Preston FE; Tedder RS
    Lancet; 1990 Oct; 336(8722):1022-5. PubMed ID: 1977017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant factor VIII concentrate. The MSAC, Canadian Hemophilia Society. Canadian Hemophilia Clinic Directors Group.
    Walker I; Poon MC
    Lancet; 1992 Jan; 339(8784):61-2. PubMed ID: 1345984
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis C antibody assay in a longitudinal study of haemophiliacs.
    Lim SG; Lee CA; Charman H; Tilsed G; Griffiths PD; Kernoff PB
    Br J Haematol; 1991 Jul; 78(3):398-402. PubMed ID: 1651756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy-induced hepatitis risk in hemophilia patients].
    Schiller WG; Renger FG
    Z Arztl Fortbild (Jena); 1983; 77(19):807-10. PubMed ID: 6417919
    [No Abstract]   [Full Text] [Related]  

  • 19. High prevalence of hepatitis C virus antibodies in a local haemophiliac population.
    du Toit JM; Brink NS; Bird AR; Robson SC; Jacobs P
    S Afr Med J; 1991 Sep; 80(6):285-6. PubMed ID: 1656535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group.
    Mannucci PM; Schimpf K; Brettler DB; Ciavarella N; Colombo M; Haschke F; Lechner K; Lusher J; Weissbach G
    Ann Intern Med; 1990 Jul; 113(1):27-32. PubMed ID: 2112352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.